Masters Capital Management LLC Gossamer Bio, Inc. Transaction History

Masters Capital Management LLC

  • $2 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$8.3 - $13.59 $5.81 Million - $9.51 Million
-700,000 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$11.3 - $14.75 $1.13 Million - $1.48 Million
100,000 Added 16.67%
700,000 $8.69 Million
Q2 2020

Aug 14, 2020
BUY
$9.52 - $15.98 $5.71 Million - $9.59 Million
600,000 New
600,000 $7.8 Million

Others Institutions Holding GOSS

# of Institutions
108
Shares Held
167M
Call Options Held
430K
Put Options Held
519K
View Full List

About Gossamer Bio, Inc.

GOSS Quotes by TradingView
  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $80.8M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track Masters Capital Management LLC Portfolio

Follow Masters Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Masters Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Masters Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email